Near-infrared  ||| S:0 E:14 ||| JJ
spectroscopy  ||| S:14 E:27 ||| NN
as  ||| S:27 E:30 ||| IN
a  ||| S:30 E:32 ||| DT
hemodynamic  ||| S:32 E:44 ||| JJ
monitor  ||| S:44 E:52 ||| NN
in  ||| S:52 E:55 ||| IN
critical  ||| S:55 E:64 ||| JJ
illness  ||| S:64 E:72 ||| NN
Near-infrared  ||| S:72 E:86 ||| JJ
spectroscopy  ||| S:86 E:99 ||| NN
has  ||| S:99 E:103 ||| VBZ
moved  ||| S:103 E:109 ||| VBN
from  ||| S:109 E:114 ||| IN
a  ||| S:114 E:116 ||| DT
research  ||| S:116 E:125 ||| NN
tool  ||| S:125 E:130 ||| NN
to  ||| S:130 E:133 ||| TO
a  ||| S:133 E:135 ||| DT
widely  ||| S:135 E:142 ||| RB
used  ||| S:142 E:147 ||| VBN
clinical  ||| S:147 E:156 ||| JJ
monitor  ||| S:156 E:164 ||| NN
in  ||| S:164 E:167 ||| IN
the  ||| S:167 E:171 ||| DT
critically  ||| S:171 E:182 ||| JJ
ill  ||| S:182 E:186 ||| JJ
pediatric  ||| S:186 E:196 ||| JJ
patient  ||| S:196 E:204 ||| NN
over  ||| S:204 E:209 ||| IN
the  ||| S:209 E:213 ||| DT
last  ||| S:213 E:218 ||| JJ
decade ||| S:218 E:224 ||| NN
.  ||| S:224 E:226 ||| .
The  ||| S:226 E:230 ||| DT
physiological  ||| S:230 E:244 ||| NN
and  ||| S:244 E:248 ||| CC
clinical  ||| S:248 E:257 ||| JJ
evidence  ||| S:257 E:266 ||| NN
supporting  ||| S:266 E:277 ||| VBG
this  ||| S:277 E:282 ||| DT
technology  ||| S:282 E:293 ||| NN
in  ||| S:293 E:296 ||| IN
practice  ||| S:296 E:305 ||| NN
is  ||| S:305 E:308 ||| VBZ
reviewed  ||| S:308 E:317 ||| VBN
here ||| S:317 E:321 ||| RB
.  ||| S:321 E:323 ||| .
A  ||| S:323 E:325 ||| DT
search  ||| S:325 E:332 ||| NN
of  ||| S:332 E:335 ||| IN
MEDLINE  ||| S:335 E:343 ||| NNP
and  ||| S:343 E:347 ||| CC
PubMed  ||| S:347 E:354 ||| NNP
was  ||| S:354 E:358 ||| VBD
conducted  ||| S:358 E:368 ||| VBN
to  ||| S:368 E:371 ||| TO
find  ||| S:371 E:376 ||| VB
validation  ||| S:376 E:387 ||| JJ
studies ||| S:387 E:394 ||| NNS
,  ||| S:394 E:396 ||| ,
controlled  ||| S:396 E:407 ||| VBN
trials ||| S:407 E:413 ||| NNS
,  ||| S:413 E:415 ||| ,
and  ||| S:415 E:419 ||| CC
other  ||| S:419 E:425 ||| JJ
reports  ||| S:425 E:433 ||| NNS
of  ||| S:433 E:436 ||| IN
near-infrared  ||| S:436 E:450 ||| JJ
spectroscopy  ||| S:450 E:463 ||| JJ
use  ||| S:463 E:467 ||| NN
in  ||| S:467 E:470 ||| IN
children  ||| S:470 E:479 ||| NNS
and  ||| S:479 E:483 ||| CC
adults  ||| S:483 E:490 ||| NNS
in  ||| S:490 E:493 ||| IN
the  ||| S:493 E:497 ||| DT
clinical  ||| S:497 E:506 ||| JJ
setting ||| S:506 E:513 ||| NN
.  ||| S:513 E:515 ||| .
Guidelines  ||| S:515 E:526 ||| NNS
published  ||| S:526 E:536 ||| VBN
by  ||| S:536 E:539 ||| IN
the  ||| S:539 E:543 ||| DT
American  ||| S:543 E:552 ||| NNP
Heart  ||| S:552 E:558 ||| NNP
Association ||| S:558 E:569 ||| NNP
,  ||| S:569 E:571 ||| ,
the  ||| S:571 E:575 ||| DT
American  ||| S:575 E:584 ||| NNP
Academy  ||| S:584 E:592 ||| NNP
of  ||| S:592 E:595 ||| IN
Pediatrics ||| S:595 E:605 ||| NNP
,  ||| S:605 E:607 ||| ,
and  ||| S:607 E:611 ||| CC
the  ||| S:611 E:615 ||| DT
International  ||| S:615 E:629 ||| NNP
Liaison  ||| S:629 E:637 ||| NNP
Committee  ||| S:637 E:647 ||| NNP
on  ||| S:647 E:650 ||| IN
Resuscitation  ||| S:650 E:664 ||| NNP
were  ||| S:664 E:669 ||| VBD
reviewed  ||| S:669 E:678 ||| VBN
including  ||| S:678 E:688 ||| VBG
further  ||| S:688 E:696 ||| JJ
review  ||| S:696 E:703 ||| NN
of  ||| S:703 E:706 ||| IN
references  ||| S:706 E:717 ||| NNS
cited ||| S:717 E:722 ||| VBD
.  ||| S:722 E:724 ||| .
The  ||| S:724 E:728 ||| DT
biophysical  ||| S:728 E:740 ||| JJ
properties  ||| S:740 E:751 ||| NNS
of  ||| S:751 E:754 ||| IN
near-infrared  ||| S:754 E:768 ||| JJ
spectroscopy  ||| S:768 E:781 ||| JJ
devices  ||| S:781 E:789 ||| NNS
allow  ||| S:789 E:795 ||| VBP
measurement  ||| S:795 E:807 ||| VBN
of  ||| S:807 E:810 ||| IN
capillary-venous  ||| S:810 E:827 ||| JJ
oxyhemoglobin  ||| S:827 E:841 ||| JJ
saturation  ||| S:841 E:852 ||| NN
in  ||| S:852 E:855 ||| IN
tissues  ||| S:855 E:863 ||| VBG
a  ||| S:863 E:865 ||| DT
few  ||| S:865 E:869 ||| JJ
centimeters  ||| S:869 E:881 ||| NNS
beneath  ||| S:881 E:889 ||| IN
the  ||| S:889 E:893 ||| DT
surface  ||| S:893 E:901 ||| NN
sensor  ||| S:901 E:908 ||| NN
with  ||| S:908 E:913 ||| IN
validated  ||| S:913 E:923 ||| JJ
accuracy  ||| S:923 E:932 ||| NN
in  ||| S:932 E:935 ||| IN
neonates ||| S:935 E:943 ||| NN
,  ||| S:943 E:945 ||| ,
infants ||| S:945 E:952 ||| NNS
,  ||| S:952 E:954 ||| ,
and  ||| S:954 E:958 ||| CC
small  ||| S:958 E:964 ||| JJ
patients ||| S:964 E:972 ||| NNS
.  ||| S:972 E:974 ||| .
The  ||| S:974 E:978 ||| DT
biologic  ||| S:978 E:987 ||| JJ
basis  ||| S:987 E:993 ||| NN
for  ||| S:993 E:997 ||| IN
the  ||| S:997 E:1001 ||| DT
relationship  ||| S:1001 E:1014 ||| NN
of  ||| S:1014 E:1017 ||| IN
capillary-venous  ||| S:1017 E:1034 ||| JJ
oxyhemoglobin  ||| S:1034 E:1048 ||| JJ
saturation  ||| S:1048 E:1059 ||| NN
to  ||| S:1059 E:1062 ||| TO
cerebral  ||| S:1062 E:1071 ||| VB
injury  ||| S:1071 E:1078 ||| NN
has  ||| S:1078 E:1082 ||| VBZ
been  ||| S:1082 E:1087 ||| VBN
described  ||| S:1087 E:1097 ||| VBN
in  ||| S:1097 E:1100 ||| IN
animal  ||| S:1100 E:1107 ||| NN
and  ||| S:1107 E:1111 ||| CC
human  ||| S:1111 E:1117 ||| JJ
studies ||| S:1117 E:1124 ||| NNS
.  ||| S:1124 E:1126 ||| .
Normal  ||| S:1126 E:1133 ||| JJ
ranges  ||| S:1133 E:1140 ||| NNS
for  ||| S:1140 E:1144 ||| IN
cerebral  ||| S:1144 E:1153 ||| NN
and  ||| S:1153 E:1157 ||| CC
somatic  ||| S:1157 E:1165 ||| JJ
capillary-venous  ||| S:1165 E:1182 ||| JJ
oxyhemoglobin  ||| S:1182 E:1196 ||| JJ
saturation  ||| S:1196 E:1207 ||| NNS
have  ||| S:1207 E:1212 ||| VBP
been  ||| S:1212 E:1217 ||| VBN
described  ||| S:1217 E:1227 ||| VBN
for  ||| S:1227 E:1231 ||| IN
normal  ||| S:1231 E:1238 ||| JJ
newborns  ||| S:1238 E:1247 ||| NNS
and  ||| S:1247 E:1251 ||| CC
infants  ||| S:1251 E:1259 ||| NNS
and  ||| S:1259 E:1263 ||| CC
children  ||| S:1263 E:1272 ||| NNS
with  ||| S:1272 E:1277 ||| IN
congenital  ||| S:1277 E:1288 ||| JJ
heart  ||| S:1288 E:1294 ||| NN
disease  ||| S:1294 E:1302 ||| NN
and  ||| S:1302 E:1306 ||| CC
other  ||| S:1306 E:1312 ||| JJ
disease  ||| S:1312 E:1320 ||| NN
states ||| S:1320 E:1326 ||| NNS
.  ||| S:1326 E:1328 ||| .
The  ||| S:1328 E:1332 ||| DT
capillary-venous  ||| S:1332 E:1349 ||| JJ
oxyhemoglobin  ||| S:1349 E:1363 ||| JJ
saturation  ||| S:1363 E:1374 ||| NN
from  ||| S:1374 E:1379 ||| IN
both  ||| S:1379 E:1384 ||| DT
cerebral  ||| S:1384 E:1393 ||| NN
and  ||| S:1393 E:1397 ||| CC
somatic  ||| S:1397 E:1405 ||| JJ
regions  ||| S:1405 E:1413 ||| NNS
has  ||| S:1413 E:1417 ||| VBZ
been  ||| S:1417 E:1422 ||| VBN
used  ||| S:1422 E:1427 ||| VBN
to  ||| S:1427 E:1430 ||| TO
estimate  ||| S:1430 E:1439 ||| VB
mixed  ||| S:1439 E:1445 ||| VBN
venous  ||| S:1445 E:1452 ||| JJ
saturation  ||| S:1452 E:1463 ||| NN
and  ||| S:1463 E:1467 ||| CC
to  ||| S:1467 E:1470 ||| TO
predict  ||| S:1470 E:1478 ||| VB
biochemical  ||| S:1478 E:1490 ||| JJ
shock ||| S:1490 E:1495 ||| NN
,  ||| S:1495 E:1497 ||| ,
multiorgan  ||| S:1497 E:1508 ||| JJ
dysfunction ||| S:1508 E:1519 ||| NN
,  ||| S:1519 E:1521 ||| ,
and  ||| S:1521 E:1525 ||| CC
mortality  ||| S:1525 E:1535 ||| NN
in  ||| S:1535 E:1538 ||| IN
different  ||| S:1538 E:1548 ||| JJ
populations ||| S:1548 E:1559 ||| NNS
.  ||| S:1559 E:1561 ||| .
The  ||| S:1561 E:1565 ||| DT
relationship  ||| S:1565 E:1578 ||| NN
of  ||| S:1578 E:1581 ||| IN
cerebral  ||| S:1581 E:1590 ||| JJ
capillary-venous  ||| S:1590 E:1607 ||| JJ
oxyhemoglobin  ||| S:1607 E:1621 ||| JJ
saturation  ||| S:1621 E:1632 ||| NN
to  ||| S:1632 E:1635 ||| TO
neuroimaging  ||| S:1635 E:1648 ||| VB
and  ||| S:1648 E:1652 ||| CC
functional  ||| S:1652 E:1663 ||| JJ
assessment  ||| S:1663 E:1674 ||| NN
of  ||| S:1674 E:1677 ||| IN
outcome  ||| S:1677 E:1685 ||| NN
is  ||| S:1685 E:1688 ||| VBZ
limited  ||| S:1688 E:1696 ||| VBN
but  ||| S:1696 E:1700 ||| CC
ongoing ||| S:1700 E:1707 ||| JJ
.  ||| S:1707 E:1709 ||| .
Although  ||| S:1709 E:1718 ||| IN
there  ||| S:1718 E:1724 ||| EX
are  ||| S:1724 E:1728 ||| VBP
numerous  ||| S:1728 E:1737 ||| JJ
conflicting  ||| S:1737 E:1749 ||| JJ
reports  ||| S:1749 E:1757 ||| NNS
in  ||| S:1757 E:1760 ||| IN
small  ||| S:1760 E:1766 ||| JJ
populations ||| S:1766 E:1777 ||| NNS
,  ||| S:1777 E:1779 ||| ,
expert  ||| S:1779 E:1786 ||| NN
opinion  ||| S:1786 E:1794 ||| NN
would  ||| S:1794 E:1800 ||| MD
suggest  ||| S:1800 E:1808 ||| VB
that  ||| S:1808 E:1813 ||| DT
special  ||| S:1813 E:1821 ||| JJ
use  ||| S:1821 E:1825 ||| NN
may  ||| S:1825 E:1829 ||| MD
exist  ||| S:1829 E:1835 ||| VB
for  ||| S:1835 E:1839 ||| IN
near-infrared  ||| S:1839 E:1853 ||| JJ
spectroscopy  ||| S:1853 E:1866 ||| NN
in  ||| S:1866 E:1869 ||| IN
patients  ||| S:1869 E:1878 ||| NNS
with  ||| S:1878 E:1883 ||| IN
complex  ||| S:1883 E:1891 ||| JJ
circulatory  ||| S:1891 E:1903 ||| JJ
anatomy ||| S:1903 E:1910 ||| NN
,  ||| S:1910 E:1912 ||| ,
with  ||| S:1912 E:1917 ||| IN
extremes  ||| S:1917 E:1926 ||| NNS
of  ||| S:1926 E:1929 ||| IN
physiology ||| S:1929 E:1939 ||| NN
,  ||| S:1939 E:1941 ||| ,
and  ||| S:1941 E:1945 ||| CC
in  ||| S:1945 E:1948 ||| IN
whom  ||| S:1948 E:1953 ||| WP
extended  ||| S:1953 E:1962 ||| VBD
noninvasive  ||| S:1962 E:1974 ||| JJ
monitoring  ||| S:1974 E:1985 ||| NN
is  ||| S:1985 E:1988 ||| VBZ
useful ||| S:1988 E:1994 ||| JJ
.  ||| S:1994 E:1996 ||| .
Class  ||| S:1996 E:2002 ||| NNP
II ||| S:2002 E:2004 ||| NNP
,  ||| S:2004 E:2006 ||| ,
level  ||| S:2006 E:2012 ||| NN
B  ||| S:2012 E:2014 ||| NN
evidence  ||| S:2014 E:2023 ||| NN
supports  ||| S:2023 E:2032 ||| VBZ
the  ||| S:2032 E:2036 ||| DT
conclusion  ||| S:2036 E:2047 ||| NN
that  ||| S:2047 E:2052 ||| IN
near-infrared  ||| S:2052 E:2066 ||| JJ
spectroscopy  ||| S:2066 E:2079 ||| NN
offers  ||| S:2079 E:2086 ||| VBZ
a  ||| S:2086 E:2088 ||| DT
favorable  ||| S:2088 E:2098 ||| JJ
risk-benefit  ||| S:2098 E:2111 ||| JJ
profile  ||| S:2111 E:2119 ||| NN
and  ||| S:2119 E:2123 ||| CC
can  ||| S:2123 E:2127 ||| MD
be  ||| S:2127 E:2130 ||| VB
effective  ||| S:2130 E:2140 ||| JJ
and  ||| S:2140 E:2144 ||| CC
beneficial  ||| S:2144 E:2155 ||| JJ
as  ||| S:2155 E:2158 ||| IN
a  ||| S:2158 E:2160 ||| DT
hemodynamic  ||| S:2160 E:2172 ||| JJ
monitor  ||| S:2172 E:2180 ||| NN
for  ||| S:2180 E:2184 ||| IN
the  ||| S:2184 E:2188 ||| DT
care  ||| S:2188 E:2193 ||| NN
of  ||| S:2193 E:2196 ||| IN
critically  ||| S:2196 E:2207 ||| JJ
patients ||| S:2207 E:2215 ||| NNS
.  ||| S:2215 E:2217 ||| .
